Titan Biotech Limited (BOM:524717)

Titan Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	16,503	18,911	3,484	4,365	1,627	2,166
Market Cap Growth	335.12%	442.88%	-20.19%	168.33%	-24.88%	41.23%
Enterprise Value	16,541	18,964	3,409	4,405	1,665	2,381
Last Close Price	399.40	457.70	84.13	105.09	38.96	51.59

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	48.71	63.28	16.18	17.56	6.55	9.99
PS Ratio	7.54	9.17	2.23	2.66	1.13	1.75
PB Ratio	9.09	10.42	2.27	3.27	1.48	2.51
P/TBV Ratio	9.09	10.42	2.27	3.27	1.48	2.51
P/FCF Ratio	71.82	82.31	32.39	262.72	19.26	13.77
P/OCF Ratio	54.25	62.17	17.31	20.64	7.68	9.82

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	7.56	9.20	2.18	2.69	1.16	1.93
EV/EBITDA Ratio	36.29	49.13	13.75	13.09	5.76	7.74
EV/EBIT Ratio	40.99	56.31	16.15	14.30	6.21	8.26
EV/FCF Ratio	71.99	82.54	31.70	265.13	19.72	15.14

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.03	0.03	0.02	0.07	0.08	0.10
Debt / EBITDA Ratio	0.13	0.15	0.13	0.26	0.29	0.29
Debt / FCF Ratio	-	0.25	0.30	5.27	1.01	0.57
Net Debt / Equity Ratio	0.02	0.02	-0.01	0.04	0.03	0.03
Net Debt / EBITDA Ratio	0.09	0.10	-0.09	0.16	0.13	0.07
Net Debt / FCF Ratio	-	0.17	-0.22	3.29	0.43	0.13
Asset Turnover	-	1.06	0.94	1.13	1.19	1.18
Inventory Turnover	-	1.81	1.54	1.88	2.01	1.78
Quick Ratio	-	0.95	1.37	1.12	1.27	1.37
Current Ratio	-	3.28	4.46	3.71	3.36	3.76
Return on Equity (ROE)	-	17.84%	15.01%	20.42%	25.33%	27.32%
Return on Assets (ROA)	-	10.83%	7.95%	13.21%	13.81%	17.25%
Return on Invested Capital (ROIC)	15.24%	14.73%	11.35%	18.54%	20.66%	25.17%
Return on Capital Employed (ROCE)	-	17.90%	13.40%	22.40%	23.50%	31.60%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	2.05%	1.58%	6.18%	5.69%	15.27%	10.01%
FCF Yield	1.39%	1.21%	3.09%	0.38%	5.19%	7.26%
Dividend Yield	0.13%	0.11%	0.47%	0.38%	0.92%	0.58%
Payout Ratio	-	5.53%	7.68%	5.99%	4.99%	5.72%
Buyback Yield / Dilution	-20.03%	-0.04%	-	-	-	-
Total Shareholder Return	-19.91%	0.07%	0.47%	0.38%	0.92%	0.58%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error